DossierENTITY

Icotyde

Coverage of Icotyde in the Nexus archive.

Earliest in view: May 16 · 12:33 UTCMost recent: May 16 · 12:33 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHMay 16 · 12:33 UTCCNBC TOP
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Johnson & Johnson's new psoriasis pill, Icotyde, is expected to accelerate the company's revenue growth rate, making it one of its biggest drugs ever. Investors are counting on this drug to drive growth. The pill's success could have a significant impact on J&J's financial performance.